Assessment of albendazole efficacy against Ascaris lumbricoides at three sites of Andhra Pradesh, Odisha, and Kerala in India

Author:

Garg Vinay1,Garg Ankur1,Garg Shubha1,Jain Sudhir Kumar2,Dikid Tanzin3,Jain Saurabh4,Manjhi Jitendra5,Montresor Antonio6,Goel Atul7

Affiliation:

1. Division of Parasitic Diseases, National Centre for Disease Control, Ministry of Health and Family Welfare, Government of India, 22-Sham Nath Marg, Civil Lines, New Delhi-110054, India

2. National Centre for Disease Control, Ministry of Health and Family Welfare, Government of India, 22-Sham Nath Marg, Civil Lines, New Delhi-110054, India

3. Epidemiology Division, National Centre for Disease Control, Ministry of Health and Family Welfare, Government of India, 22-Sham Nath Marg, Civil Lines, New Delhi-110054, India

4. Department of Control of Neglected Tropical Diseases (NTD), World Health Organization (WHO), Av Appia 20 CH-1211, Geneva 27, Switzerland

5. Department of Community & Family Medicine, AIIMS Kalyani, India

6. Community and Primary Care-based Intervention, Department of Control of Neglected Tropical Diseases (NTD), World Health Organization (WHO), Av Appia 20 CH-1211, Geneva 27, Switzerland

7. Director General of Health Sciences (DGHS) & Director, National Centre for Disease Control, Ministry of Health and Family Welfare, Government of India, 22-Sham Nath Marg, Civil Lines, New Delhi-110054, India

Abstract

Objective: To assess efficacy of albendazole against Ascaris (A.) lumbrìcoides among school-children at three sites of Rajahmundry, Sundergarh and Wayanad. Methods: Sites were selected based on soil-transmitted helminths prevalence, different sociocultural-geographical characteristics and operational feasibility. 9-12 Years old children from 14 schools were included. The study was conducted in two rounds: baseline & follow up survey. All eligible children found positive for A. lumbricoides at baseline were administered supervised single tablet albendazole 400 mg under the National Deworming Day Initiative. During post-treatment follow-up survey, eligible children who provided second stool sample were included in the final analysis. Stool samples were examined using WHO recommended Kato-Katz technique. Efficacy was estimated based on cure rate (CR) and Fecal Egg Count Reduction Rate (FECRR) among children found positive in baseline and follow-up surveys. Results: 328 Out of 625 (52.5%) were found positive for A. lumbricoides in the baseline survey and 85 out of 178 samples (47.8%) during post-treatment follow-up survey. Overall, the estimated CR was 52.2%. FECRR (95% CI) for albendazole was 72.6% (79.2%-66.0%). The FECRR was highest in East Godaveri [89.7% (96.8%-82.6%)], followed by Sundergarh [86.4% (95.3%-77.5%)] and Wayanad [69% (81.7%-56.4%)]. Conclusions: Our study confirmed overall reduction in FEC although with varying albendazole efficacy for A. lumbricoides infection at three different locations in India. However, these finding may be assessed in context of ongoing MDA under Filaria control program and further studies by in vivo as well as in vitro methods are required to reach to a conclusion on possible resistance if any.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3